Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review

Overview of attention for article published in BMC Neurology, May 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis.

Article in Aging and Disease (April 2024)

Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders

Article in Basic & Clinical Pharmacology & Toxicology (March 2024)

Motor and non-motor symptoms, drugs, and their mode of action in Parkinson’s disease (PD): a review

Article in Medicinal Chemistry Research (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.